Investment
Investing at the Intersection of Industrial Manufacturing and Healthcare
David Q. Anderson
Ampersand Capital Partners
PAP-Q2-20-CL-025Jul 01, 2020
Viral Vector Manufacturing
Accelerating The Development of Viral Vector Manufacturing Processes
Richard Snyder, Ph.D.; Clive Glover, Ph.D.; Rajiv Vaidya, Ph.D.; Matt Niloff
Thermo Fisher Scientific
PAP-Q2-2019-CL-009May 24, 2019
Executive Q&A
Q&A: Building a Successful CDMO Brand
Ampersand Capital Partners
PAP-Q2-2019-CL-024May 24, 2019
M&A
Brammer Bio Purchased by Thermo Fisher Scientific
Nice Insight
PAO-M03-19-NI-032Mar 28, 2019
Acquistion
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
Brammer Bio
PR-M03-19-NI-078-2821Mar 25, 2019
QPCR
Digital Droplet PCR for Viral Vector Analysis
Richard Snyder, Ph.D.; Susan D'Costa, Ph.D.; Sushma Ogram, Ph.D.; Diego Matayoshi
Thermo Fisher Scientific
PAP-Q1-2019-CL-005Mar 12, 2019
Facility
DPS Group Selected to Design Two cGMP Commercial Manufacturing Facilities for Brammer Bio
Brammer Bio
PR-M01-19-NI-036-3172Jan 09, 2019
Appointment
Brammer Bolsters Leadership Team and Announces Chief Quality Officer
Brammer Bio
PR-M01-19-NI-019Jan 04, 2019
Viral Vector Manufacturing
From Proof of Concept to Commercialization
Brammer Bio
PAP-Q4-18-CL-003Oct 26, 2018
Cell and Gene Therapy
Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing
Richard Snyder, Ph.D.; Sushma Ogram, Ph.D.; Tony DeFusco
Thermo Fisher Scientific
PAP-Q3-18-CL-001Oct 02, 2018
Cell and Gene Therapy
Brammer Bio Announces Progress on $200 Million Program to Advance Gene Therapies
Brammer Bio
PR-M09-18-NI-096Sep 26, 2018
Cell and Gene Therapy
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
Richard Snyder, Ph.D.; Christopher K. Murphy; Susan D'Costa, Ph.D.; Cameron Jones
Thermo Fisher Scientific
PAP-Q2-18-CL-011May 29, 2018
Appointment
Brammer Bio Expands Leadership Team for Commercial Readiness
Brammer Bio
PR-M03-18-NI-080Mar 22, 2018
Viral Vector
Ensuring Confidence in Viral Vector Manufacturing
Michael Wourms; Christopher K. Murphy
Arranta Bio
PAP-Q1-18-CL-012Mar 12, 2018
Cell and Gene Therapy
Brammer Bio Supports Rare Disease Day 2018
Brammer Bio
PR-M03-18-NI-006Mar 01, 2018
Cell and Gene Therapy
Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts
Nice Insight
PAO-M12-17-NI-006-5009Dec 05, 2017
Bioprocessing
Brammer Bio Leverages Advanced Bioprocessing Technologies to Accelerate Capacity
Nice Insight
PAO-M10-17-NI-002Oct 03, 2017
Transient Transfection
Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing
Richard Snyder, Ph.D.; Scott Jeffers, Ph.D.; Ying Cai, Ph.D.
Thermo Fisher Scientific
PAP-Q3-17-CL-005Sep 15, 2017
CDMO
Supporting the Tech Transfer Continuum for Cell & Gene Therapies
Richard Snyder, Ph.D.; Matthew Caple; Jessica Tate, Ph.D.
Thermo Fisher Scientific
PAP-Q2-17-CL-003Jun 05, 2017
Investing for Successful Advancement of Viral Vector Manufacturing
Brammer Bio
PAP-Q1-17-CL-007Mar 08, 2017